Articles tagged with “fcrn-inhibitors”

Vyvgart gMG Label Expansion: Triple Seronegative Subtypes

An analysis of the May 2026 FDA label expansion for Vyvgart (efgartigimod) in generalized myasthenia gravis, covering triple seronegative subtypes and markets.

30 min read

5/3/2026

vyvgart label expansion generalized myasthenia gravis efgartigimod fcrn inhibitors triple seronegative gmg argenx autoimmune neurology